Lv3
250 积分 2024-09-25 加入
Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia
9天前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
9天前
已完结
Resetting autoimmune disease with CAR cell therapies
13天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
13天前
已完结
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
14天前
已完结
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
17天前
已完结
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
21天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
1个月前
已完结
Genome diversity and signatures of natural selection in mainland Southeast Asia
1个月前
已完结
The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects
1个月前
已完结
皖公网安备34019202002308
